Targeting skeletal muscle AMP-activated protein kinase to treat type 2 diabetes

Journal article

Peer reviewed

Eric B Taylor and Laurie J Goodyear

Current diabetes reports, Vol.7(6), pp.399-401

12/2007

DOI: 10.1007/s11892-007-0065-8

PMID: 18254999

View Online

no abstract | commentary

Enzyme Activators - pharmacology

Hypoglycemic Agents - therapeutic use

Muscle, Skeletal - enzymology

Enzyme Activators - therapeutic use

Aminoimidazole Carboxamide - therapeutic use

Humans

Diabetes Mellitus, Type 2 - enzymology

Multienzyme Complexes - metabolism

Enzyme Activation - drug effects

AMP-Activated Protein Kinases

Protein Subunits - metabolism

Aminoimidazole Carboxamide - pharmacology

Hypoglycemic Agents - pharmacology

Ribonucleotides - pharmacology

Ribonucleotides - therapeutic use

Animals

Aminoimidazole Carboxamide - analogs & derivatives

Muscle, Skeletal - drug effects

Mice

Diabetes Mellitus, Type 2 - drug therapy

Protein-Serine-Threonine Kinases - metabolism

Title: Subtitle: Targeting skeletal muscle AMP-activated protein kinase to treat type 2 diabetes
Creators: Eric B Taylor - The Joslin Diabetes Center and Harvard Medical School, 1 Joslin Place, Boston, MA 02215, USA. laurie.goodyear@joslin.harvard.edu
Laurie J Goodyear
Resource Type: Journal article
Publication Details: Current diabetes reports, Vol.7(6), pp.399-401
Publisher: United States
DOI: 10.1007/s11892-007-0065-8
PMID: 18254999
ISSN: 1534-4827
eISSN: 1539-0829
Language: English
Date published: 12/2007
Academic Unit: Molecular Physiology and Biophysics
Record Identifier: 9984025581602771

12 Record Views